Rocket Lab SEC Filings

Rocket Lab officer Arjun Kampani filed Form 144 on June 2, 2025, to sell 5,194 common shares acquired from vested RSUs on May 22, 2025, valued at $139,147. The sale is pursuant to a Rule 10b5-1 plan adopted December 12, 2024. Recent sales by Kampani total about 68,478 shares worth ~$1.56M in the past three months, routine for insider liquidity.

Rocket Lab officer Frank Klein filed Form 144 on June 2, 2025, notifying intent to sell 1,818 common shares (value $48,704) acquired via RSU vesting on May 22, 2025. Sales follow recent transactions totaling ~93,436 shares worth ~$2.12M in past 3 months, all under a 10b5-1 plan adopted December 13, 2024. Routine disclosure signals planned diversification, relevant for monitoring insider activity.

This 424B5 supplements the March 11, 2025 ATM filing for up to $500 million in common stock sales. It discloses a May 23, 2025 reorganization creating Rocket Lab Corporation as the new parent, which assumed the sales agreement. Approximately $397.7 million remains available under the ATM.

Frank Klein, Chief Operations Officer, sold 2,569 shares of common stock on May 28, 2025, at a weighted average price of $29.97. The transaction was automatic under a Rule 10b5-1 plan adopted December 13, 2024. Neutral signal due to pre-planned nature.

Arjun Kampani, Senior Vice President, General Counsel and Secretary at Rocket Lab USA, sold 5,277 shares of common stock on May 28, 2025, at $29.97 per share. The sale was automatic under a Rule 10b5-1 trading plan adopted on December 12, 2024. This represents a neutral signal due to the pre-scheduled nature of the transaction.

Rocket Lab officer Arjun Kampani filed Form 144 on 2025-05-30 to sell 28,988 common shares (21,371 + 7,617) valued at ~$773k on NASDAQ via Morgan Stanley. Shares stem from restricted stock units vesting on 2025-05-22 as compensation. This routine insider transaction certifies no undisclosed material adverse information.

Form 144 filed by Rocket Lab officer Frank Klein discloses intent to sell 44,885 common shares valued at $1,196,672 on May 30, 2025. Shares stem from vesting of 81,250 restricted stock units on May 22, 2025, as compensation. Sale covers tax liabilities from vesting; recent 3-month sales total 48,957 shares for ~$920k.

Form 144 discloses Rocket Lab officer Adam C. Spice's intent to sell 63,444 common shares valued at $1.69M on 05/30/2025. Shares originate from 114,846 RSUs vesting on 05/22/2025, with sale covering tax obligations. This follows a prior sale of 62,843 shares on 03/14/2025 for $1.14M; routine insider liquidity event.

This is a Notice of Effectiveness for submission type POS AM. The SEC confirmed effectiveness on May 28 2025 for file 333-257440. Investors should note the registration statement is now active.

This is a Notice of Effectiveness for Rocket Lab Corp's post-effective amendment (POS AM) to its registration statement. The SEC declared it effective on May 28, 2025 under file number 333-259797. This allows the company to proceed with securities offerings under the updated registration.